期刊文献+

E-cadherin对非小细胞肺癌的转移和靶向治疗的影响 被引量:1

Impact of E-cadherin on Metastasis and Molecular Targeted Therapy in Non-small Cell Lung Cancer
下载PDF
导出
摘要 E-cadherin是维持上皮细胞极性和上皮完整性的重要分子,也是细胞上皮表型的主要标志.在肿瘤发生侵袭和转移的过程中上皮-间质转化(epithelial-mesenchymal transition,EMT)起了重要的作用,E-cadherin蛋白的表达缺失是EMT发生的主要标志.E-cadherin的异常表达对非小细胞肺癌的转移及患者的靶向治疗效果均有影响,就E-cadherin在非小细胞肺癌的转移和靶向治疗中的作用进行综述. E-cadherin is a key molecule in maintaining cell polarity and epithelial integerity, and it is themain symbol of epithelial phenotype. The process of epithelial-mesenchymal transition (EMT) plays a critical role in the invasion and metastasis of tumor, while the deletion of E-cadherin protein expression is a defining characteristic of EMT. The abnormal expression of E-cadherin is associated with both metastasis and molecular targeted therap metastasis and y of patients with non-small ceil lung cancer. This review summarizes the relation of E-cadherin with molecular targeted therapy in non-small cell lung cancer.
出处 《昆明医科大学学报》 CAS 2014年第4期164-167,共4页 Journal of Kunming Medical University
基金 国家自然科学基金资助项目(81060189) 云南省自然科学基金资助项目(2010ZC107)
关键词 E-CADHERIN 非小细胞肺癌 转移 分子靶向治疗 E-cadherin Carcinoma Non-small-cell lung Metastasis Molecular targetedtherapy
  • 相关文献

参考文献21

  • 1VAISSIERE T, HUNG R J,ZARIDZE D,et al. Quantita- tive analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors [J].Cancer Res, 2009,69( 1 ):243--252. 被引量:1
  • 2ZHENG S Y, HOU J Y, ZHAO J, et al. Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer [J]. Asian Pac J Cancer Prey,2012,13 (4):1 557--1 561. 被引量:1
  • 3HURTEAU G J,CARLSON J A,ROOS E,et al. Stable ex- pression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin ex pression [J]. Cell Cycle, 2009,8( 13 ):2 064--2 069. 被引量:1
  • 4CAO M, SEIKE M, SOENO C, et al. MiR-23a regulates T- GF-beta-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells[J]. Int J Oncol, 2012,41(3):869--875. 被引量:1
  • 5WANG G, DONG W, SHEN H, et al. A comparison of twist and e-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases [J]. Eur J Cardiothorac Surg,2011,39 (6):1 028-- 1 032. 被引量:1
  • 6KAKIHANA M, OHIRA T, CHAN D, et al.lnduction of ec- adherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition [J ]. J Thorac Oncol, 2009, 4(12):1455-1465. 被引量:1
  • 7CEPPI P, MUDDULURU G, KUMARSWAMY R, et al. L- oss of miR-200 c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer[J]. Mol Cancer Res, 2010,8 ( 9 ) : 1 207 -- 1 216. 被引量:1
  • 8MITSELOU A, BATISTATOU A, NAKANISHI Y, et al. C- omparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites [J]. Histol Histopathol, 2010, 25(10):1 257--1 267. 被引量:1
  • 9NAM J S, HIROHASHI S, WAKEFIELD L M. Dysadher- in: a new player in cancer progression [J]. Cancer Lett, 2007,255(2):161--169. 被引量:1
  • 10ONO K, URAMOTO H, HANAGIRI T. Expression of dys- adherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC [J]. Anticancer Res, 2010,30(9):3 273-- 3 278. 被引量:1

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部